Eric Davis

984 total citations
29 papers, 698 citations indexed

About

Eric Davis is a scholar working on Hematology, Transplantation and Surgery. According to data from OpenAlex, Eric Davis has authored 29 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Hematology, 13 papers in Transplantation and 7 papers in Surgery. Recurrent topics in Eric Davis's work include Renal Transplantation Outcomes and Treatments (13 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Acute Myeloid Leukemia Research (7 papers). Eric Davis is often cited by papers focused on Renal Transplantation Outcomes and Treatments (13 papers), Hematopoietic Stem Cell Transplantation (10 papers) and Acute Myeloid Leukemia Research (7 papers). Eric Davis collaborates with scholars based in United States, Czechia and Italy. Eric Davis's co-authors include Onsi W. Kamel, Roger A. Warnke, Gerald J. Berry, David P. LeBrun, Peter H. Wiernik, Elisabeth Paietta, Jacob M. Rowe, Peter L. Greenberg, Branimir I. Šikić and Kathleen Dugan and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Eric Davis

27 papers receiving 677 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eric Davis United States	12	320	263	207	110	94	29	698
C. Michel Zwaan Netherlands	18	280 0.9×	313 1.2×	293 1.4×	147 1.3×	139 1.5×	74	943
Anand P. Jillella United States	15	280 0.9×	485 1.8×	314 1.5×	222 2.0×	44 0.5×	55	866
Wichai Chinratanalab United States	11	512 1.6×	413 1.6×	314 1.5×	99 0.9×	49 0.5×	48	1.0k
Shilpa Paul United States	13	232 0.7×	294 1.1×	122 0.6×	180 1.6×	74 0.8×	41	670
Kenneth B. DeSantes United States	16	354 1.1×	322 1.2×	275 1.3×	108 1.0×	91 1.0×	32	1.1k
Rita Assi United States	13	237 0.7×	388 1.5×	230 1.1×	137 1.2×	27 0.3×	49	824
Israel Bendit Brazil	17	208 0.7×	423 1.6×	197 1.0×	296 2.7×	39 0.4×	82	818
David Topolsky United States	15	348 1.1×	337 1.3×	83 0.4×	93 0.8×	30 0.3×	39	884
Jacques Camerlo France	18	448 1.4×	212 0.8×	172 0.8×	105 1.0×	23 0.2×	50	932
Martine George United States	9	277 0.9×	179 0.7×	120 0.6×	64 0.6×	61 0.6×	16	898

Countries citing papers authored by Eric Davis

Since Specialization

Citations

This map shows the geographic impact of Eric Davis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Davis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Davis more than expected).

Fields of papers citing papers by Eric Davis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Davis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Davis. The network helps show where Eric Davis may publish in the future.

Co-authorship network of co-authors of Eric Davis

This figure shows the co-authorship network connecting the top 25 collaborators of Eric Davis. A scholar is included among the top collaborators of Eric Davis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric Davis. Eric Davis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Anděra, Ladislav, Adéla Berková, Zuzana Zemanová, et al.. (2024). Impact of PIK3CA gain and PTEN loss on mantle cell lymphoma biology and sensitivity to targeted therapies. Blood Advances. 8(20). 5279–5289. 2 indexed citations

2.

Fingrut, Warren, Eric Davis, Samantha Brown, et al.. (2024). Racial/ethnic disparities in availability of volunteer unrelated donors for allogeneic transplantation. Blood Advances. 8(11). 2753–2764. 6 indexed citations

3.

Fingrut, Warren, Jessica Flynn, Eric Davis, et al.. (2023). Association between non-European ancestry, low socioeconomic status, and receipt of HLA-disparate allografts in adult BMT recipients. Blood Advances. 7(15). 3834–3837. 4 indexed citations

4.

Fingrut, Warren, Eric Davis, Samantha Brown, et al.. (2023). Gender disparities in allograft access due to HLA-sensitization in multiparous women. Blood Advances. 8(2). 403–406. 2 indexed citations

5.

Boelens, Jaap Jan, Susan E. Prockop, Kevin J. Curran, et al.. (2023). Excellent leukemia control after second hematopoietic cell transplants with unrelated cord blood grafts for post-transplant relapse in pediatric patients. Frontiers in Oncology. 13. 1221782–1221782. 5 indexed citations

6.

Fingrut, Warren, Eric Davis, Samantha Brown, et al.. (2023). Analysis of 3,843 Unrelated Donors (URD) for 455 Allograft Candidates Reveals Low URD Availability with Marked Racial/ Ethnic Disparities: Major Implications for Transplant Center & Registry Operations. Blood. 142(Supplement 1). 5114–5114. 1 indexed citations

7.

Fingrut, Warren, Eric Davis, Samantha Brown, et al.. (2023). Gender Disparities in Allograft Access Due to HLA-Sensitization in Multiparous Women: Implications for Evaluation of Female Patients for Alternative Donor Transplantation. Blood. 142(Supplement 1). 3759–3759. 1 indexed citations

8.

Davis, Eric, Jessica Flynn, Deborah Wells, et al.. (2023). An Optimized Search Prognosis Tool to Predict 8/8 HLA Allele-Matched Unrelated Donor Procurement. Transplantation and Cellular Therapy. 29(5). 312.e1–312.e5. 5 indexed citations

9.

Fingrut, Warren, Boglarka Gyurkocza, Jessica Flynn, et al.. (2022). Analysis of disparities in time to allogeneic transplantation in adults with acute myelogenous leukemia. Blood Advances. 7(15). 3824–3833. 11 indexed citations

10.

Politikos, Ioannis, Eric Davis, John E. Wagner, et al.. (2020). Guidelines for Cord Blood Unit Selection. Biology of Blood and Marrow Transplantation. 26(12). 2190–2196. 38 indexed citations

11.

Barker, Juliet N., Sean M. Devlin, Eric Davis, et al.. (2019). Evaluation of Cord Blood Total Nucleated and CD34+ Cell Content, Cell Dose, and 8-Allele HLA Match by Patient Ancestry. Biology of Blood and Marrow Transplantation. 26(4). 734–744. 9 indexed citations

12.

Barker, Juliet N., Kirsten M Boughan, Parastoo B. Dahi, et al.. (2019). Racial disparities in access to HLA-matched unrelated donor transplants: a prospective 1312-patient analysis. Blood Advances. 3(7). 939–944. 63 indexed citations

13.

Davis, Eric, Sean M. Devlin, Jennifer Paulson, et al.. (2017). Validation of an Algorithm to Predict the Likelihood of an 8/8 HLA-Matched Unrelated Donor at Search Initiation. Biology of Blood and Marrow Transplantation. 24(5). 1057–1062. 15 indexed citations

14.

Kosuri, Satyajit, Sean M. Devlin, Courtney Byam, et al.. (2017). Prospective Evaluation of Unrelated Donor Cord Blood and Haploidentical Donor Access Reveals Graft Availability Varies by Patient Ancestry: Practical Implications for Donor Selection. Biology of Blood and Marrow Transplantation. 23(6). 965–970. 26 indexed citations

15.

Advani, Ranjana H., Giuseppe Visani, D Milligan, et al.. (1999). Treatment of Poor Prognosis AML Patients Using PSC833 (Valspodar) Plus Mitoxantrone, Etoposide, and Cytarabine (PSC-MEC). Advances in experimental medicine and biology. 457. 47–56. 33 indexed citations

16.

Advani, Ranjana H., Hussain I. Saba, Martin S. Tallman, et al.. (1999). Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar). Blood. 93(3). 787–795. 109 indexed citations

17.

Advani, Ranjana H., Hussain I. Saba, Martin S. Tallman, et al.. (1999). Treatment of Refractory and Relapsed Acute Myelogenous Leukemia With Combination Chemotherapy Plus the Multidrug Resistance Modulator PSC 833 (Valspodar). Blood. 93(3). 787–795. 124 indexed citations

18.

Kamel, Onsi W., David P. LeBrun, Eric Davis, Gerald J. Berry, & Roger A. Warnke. (1991). Growth fraction estimation of malignant lymphomas in formalin-fixed paraffin-embedded tissue using anti-PCNA/Cyclin 19A2. Correlation with Ki-67 labeling.. PubMed. 138(6). 1471–7. 135 indexed citations

19.

Madison, J, K. Arai, Yasushi Sakamoto, et al.. (1991). Genetic variants of serum albumin in Americans and Japanese.. Proceedings of the National Academy of Sciences. 88(21). 9853–9857. 25 indexed citations

20.

Huszár, Gábor, et al.. (1982). Effects of acute cold exposure on muscle amino acid and protein in rats. Journal of Applied Physiology. 52(5). 1250–1256. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact